HowardMSandlerMDFASTRO

PubMed

• 3 citations
  Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials.
  Praful Ravi, Wanling Xie, Marc Buyse, Susan Halabi, Philip W Kantoff
  European Urology. 2025-02-01
• Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens.
  Brennan T Flannery, Howard M Sandler, Priti Lal, Michael D Feldman, Juan C Santa-Rosario
  The Journal of Pathology. 2025-02-01
• The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials.
  John Nikitas, Parsa Jamshidian, Alison C Tree, Emma Hall, David Dearnaley
  The Lancet. Oncology. 2025-01-30

Journal Articles

• Analysis of the possibility that transurethral resection promotes metastasis in prostate cancer.  
  Sandler H, Hanks G, Cancer 62:2622-2627
• Intraoral hyperthermia using microwave antennae and a dental mould.  
  Chu JCH, Sandler HM, Curran WJ, Shammo G, Stafford PM, Richter MP, Hanks GE, Endocurietherapy/Hyperthermia Oncology 5:121-125
• Results of radiotherapy for thyroid ophthalmopathy.  
  Sandler HM, Rubenstein JH, Fowble BL, Sergott RC, Savino PJ, Bosley TM, Int J Radiat Oncol Biol Phys 17:823-827
• The role of the H-ras oncogene in radiation resistance and metastasis.  
  McKenna WG, Weiss MC, Bakanauskas VJ, Sandler HM, Kelsten ML, Biaglow J, Tuttle SW, Endlich B, Ling CC, Muschel RJ, Int J Radiat Oncol Biol Phys 18:849-859
• The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer.  
  Sandler HM, Curran WJ, Turrisi AT, Int J Radiat Oncol Biol Phys 19:9-13
• Malignant astrocytomas: Focal tumor recurrence after focal external beam radiation therapy (FEBRT).  
  Liang BC, Thornton AF, Sandler HM, Greenberg HS, Journal of Neurosurgery 75:559-563
• Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution.  
  Sandler HM, McShan DL, Lichter, AS, Int J Radiat Oncol Biol Phys 22:361-367
• Dose escalation for stage C (T3) prostate cancer: Minimal rectal toxicity observed using conformal therapy.  
  Sandler HM, Perez-Tamayo C, Ten Haken RK, Lichter AS, Radiotherapy and Oncology 23:53-54
• Spinal cord astrocytomas - results of therapy.  
  Sandler HM, Papadopoulos SM, Thornton AF, Ross D, Neurosurgery 30:490-493
• Adverse influence of younger age on outcome in patients with non-small cell lung carcinoma (NSCLC) treated with radiation therapy (RT) alone.  
  Herbert SH, Curran WJ Jr, Rosenthal SA, Stafford PM, McKenna WG, Hughes EN, Sandler HM, Int J Radiat Oncol Biol Phys 24:37-42
• Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?  
  Curran WJ Jr, Herbert SH, Stafford PM, Sandler HM, Rosenthal S, McKenna WG, Hughes E, Dougherty MJ, Keller S, Int J Radiat Oncol Biol Phys 24:25-30
• Clinical stage II non-small cell lung cancer (NSCLC) treated with radiation therapy (RT) alone: The significance of clinically staged ipsilateral hilar adenopathy (N1 ...  
  Rosenthal SA, Curran WJ Jr, Herbert SH, Hughes EN, Sandler HM, Stafford PM, McKenna WG, Cancer 70:2410-2417
• The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms.  
  Thornton AF, Sandler HM, Ten Haken RK, McShan DL, Fraass BA, LaVigne ML, Yanke BR, Int J Radiat Oncol Biol Phys 24:767-775
• A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumors.  
  Ten Haken RK, Thornton AF, Sandler HM, LaVigne ML, Quint DJ, Fraass BA, Kessler ML, McShan DL, Radiotherapy and Oncology 25:121-133
• A customized non-axial external beam technique for treatment of prostate carcinomas.  
  Marsh LH, Ten Haken RK, Sandler HM, Med Dosim 17:123-127
• A primary central nervous system T-cell lymphoma in a renal transplant patient.  
  Hacker SM, Knight B, Lunde NM, Gratiot-Deans J, Sandler HM, Leichtman AB, The Transplantation 53:691-692
• Treatment of T3a bladder cancer with iridium implantation.  
  Grossman HB, Sandler HM, Perez-Tamayo C, Urology 41:217-220
• Myxopapillary ependymoma: Report of 13 cases and the results of nucleolar organizing region staining.  
  Ross DA, McKeever PE, Sandler HM, Muraszko KM, Cancer 71:3114-3118
• Localization of the prostatic apex for radiation therapy using implanted markers.  
  Sandler HM, Bree RL, McLaughlin PW, Grossman HB, Lichter AS, Int J Radiat Oncol Biol Phys 27:915-919
• Primary central nervous system lymphoma: Treatment with multiagent systemic and intrathecal chemotherapy with radiation therapy.  
  Liang BC, Grant R, Junck L, Sandler HM, Papadopoulos SM, Kaminski MS, Greenberg HS, International Journal of Oncology 3:1001-1004
• Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinus.  
  Roa WHY, Hazuka MB, Martel MK, Sandler HM, Thornton AF, Turrisi AT, Urba S, Wolf GT, Lichter AS, Int J Radiat Oncol Biol Phys 28:857-865
• Pelvic CT findings after radical prostatectomy.  
  Summers RM, Korobkin M, Quint LE, Ellis JH, Grossman HB, Sandler HM, Mandell SH, J Comput Assist Tomogr 17:767-771
• Cystic cervical intramedullary ependymoma with previous intracyst hemorrhage: MR imaging at 1.5T.  
  Sweasey TA, Brunberg JA, McKeever PE, Sandler HM, Chandler WF, J Neuroimaging 4:111-113
• Metastatic epidural spinal cord compression: Current concepts and treatment.  
  Grant R, Papadopoulos SM, Sandler HM, Greenberg HS, Journal of Neuro-Oncology 19:79-92
• Radiosensitization with carotid intra-arterial bromodeoxyuridine ± 5-fluorouracil biomodulation for malignant gliomas.  
  Greenberg HS, Chandler WF, Ensminger WD, Sandler H, Junck L, Page MA, Crane D, McKeever P, Tankanow R, Bromberg J, Neurology 44:1715-1720
• Join now to see all

Books/Book Chapters

•  
  Chapter: Abeloff’s Clinical Oncology 
  Smith DC, Montie JE, Sandler HMEditors: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG.Churchill Livingstone, New YorkEdition 4,
•  
  Pienta KJ, Sandler HM, Wilson TGEditors: Pazdur R, Coia LR, Hoskins WJ, Wagman LD.Huntington, NYEdition 2,
•  
  Chapter: Non-axial, external beam treatment for prostate cancer 
  Sandler HMEditors: D'Amico A and Hanks GE.Arnold, Ltd, London
•  
  Chapter: Melanoma 
  Chang AE, Johnson TM, Smith DC, Sandler HMEditors: Torosian MH.Marcel Dekker, New York
•  
  Chapter: The biological effects of ionizing radiation on normal and abnormal nervous systems 
  Lee SW, Sandler HMEditors: : Crockard A, Hayward R, and Hoff J.Blackwell ScienceEdition 3,
•  
  Chapter: Carcinoma of the bladder 
  Montie JE, Smith DC, Sandler HMEditors: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE.Churchill Livingstone, New YorkEdition 2,
•  
  Pienta, KJ, Sandler H, Javidan J, Sanda MGEditors: Pazdur R, Coia LR, Hoskins WJ, Wagman LD.Huntington, NY
•  
  Chapter: Clinical Oncology 
  Montie JE, Smith DC, Sandler HMEditors: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG.Churchill Livingstone, New York
•  
  Chapter: Prostate Cancer: A Clinical Guide. Philadelphia 
  Sandler HMEditors: Gulley JL, Dahut WL, Moul JW, Sandler HM.Lippincott, Williams & Wilkins
•  
  Chapter: Grade 2 toxicity on RTOG 9406: Robbing Peter to pay Paul? 
  Page 48 - 54Michalski JM, Winter K, Purdy JA, Wilder R, Perez CA, Roach M, Parliament MB, Pollack A, Markoe A, Harms WB, Sandler HM, Cox JDEditors: Paliwal BR.Medical Physics Publishing
•  
  Chapter: Radiation Oncology: A Question-Based Review 
  Zeng J and Sandler HEditors: Hristov B, Lin SH, Christodouleas JP.Lippincott
•  
  Lichter AS, Sandler HM, Thornton AF, Schoeppel SL, Lawrence TSEditors: Dewey WC, Edington M, Fry RJM, Hall J, Whitmore GF.
•  
  Page 217 - 219Greenberg HS, Chandler WF, Ensminger WD, Junck L, Thornton A, Sandler HM, Page MA, McKeever P, Gebarski S, Liang B, Tankanow REditors: Paoletti P.Kluwer Academic Publishers
•  
  Page 176 - 181Greenberg HS, Chandler WF, Ensminger WD, Junck L, Page MA, Thornton AF, Sandler HM, Gebarski SS, McKeever P, Papadopoulos S, Stetson PL, Tankanow REditors: European Review of Biomedical Technology Paris, France.Sepsi Publishing
•  
  Howard M. SandlerEditors: Gulley JL, Dahut WL, Moul JW, Sandler HM.Lippincott, Williams & Wilkins
•  
  Howard M. SandlerEditors: Nargund V, Raghavan D, Sandler HM.Springer
•  
  Greenberg HS, Chandler WF, Sandler HMPhiladelphia: FA Davis Co
• Join now to see all

Abstracts/Posters

• Dose escalation with external beam radiotherapy for prostate cancer.
  Sandler HM, Front Radiat Ther Oncol 34:158-164
• Comparison of two types of ASTRO consensus definitions of biochemical failure: Secondary analysis of Radiation Therapy Oncology Group (RTOG) 92-02 and 94-13.
  Pan CC, Bae K, Hanks G, Shipley W, Roach M, Lawton CA, Sandler HM, Int J Radiat Oncol Biol Phys
• Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates—the Massachusetts ...
  Shipley WU, Zietman AL, Kaufman DS, Coen JJ, Sandler HM, Seminars in Radiation Oncology 15:36-41
• Organ preservation in muscle invasive bladder cancer.
  Fernando SA, Sandler HM, Oncology 19:334-339
• Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer.
  Hollenbeck BK, Dunn RL, Wei JT, Sandler HM, Sanda MG, Current Urology Reports 5:212-219
• Rationale for the Radiation Therapy Oncology Group study RTOG P-0014.
  Sandler HM, Pienta KJ, Rev Urol. 5(suppl 3):S45-S51
• Combined modality treatment for prostate cancer: Role of chemotherapy.
  Sandler HM, Narayan S, Smith DC, Seminars in Radiation Oncology 30(4 Suppl 9):95-100
• Chemotherapy for localized, high risk prostate cancer.
  Narayan S, Smith DC, Sandler HM, Seminars in Radiation Oncology 13:152-157
• Dose escalation for prostate cancer: Which dose for which person?
  Sandler HM, Front Radiat Ther Oncol 36:10-15
• Clinical experience with 3-dimensional treatment planning.
  Lichter AS, Sandler HM, Robertson JM, Lawrence TS, Ten Haken RK, McShan DL, Fraass BA, Seminars in Radiation Oncology 2:257-266
• Optimization and clinical use of multisegment IMRT for high dose conformal therapy.
  Fraass BA, Kessler ML, McShan DL, Marsh LH, Watson BA, Dusseau WJ, Eisbruch A, Sandler HM, Lichter AS, Seminars in Radiation Oncology 9:60-77
• Controversies in the management of stage I seminoma.
  Fiveash J, Sandler HM, Oncology 12:1203-1212
• Advances in radiotherapy for prostate cancer.
  Sandler H, McLaughlin P, Michigan Oncology Journal Fall 1998
• The Evan Shapiro case study: Stevens-Johnson syndrome.
  Rao G, Sandler H, Michigan Oncology Journal Summer
• The National Comprehensive Cancer Network.
  Baker LH, Hanks G, Gershenson D, Kantoff P, Lange P, Logothetis C, Sandler H, Walsh P, NCCN Prostate Cancer Practice Guidelines-Oncology 10:265-88
• 3-D conformal radiotherapy for brain tumors. The University of Michigan experience.
  Sandler HM, Front Radiat Ther Oncol 29:250-254, Ann Arbor, USA
• 3-D conformal radiotherapy for prostate cancer. The University of Michigan experience.
  Sandler HM, Front Radiat Ther Oncol 29:250-254, Ann Arbor, USA
• Determining local-regional extension of prostate cancer.
  Sandler HM, Ohl DA, Quint LE, Bree RL, Seminars in Radiation Oncology 3:169-178
• Join now to see all